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SUMMARY : A case of retroperitoneal CASTLEMAN's disease of hyaline-vascular 
type is presented. A 58-year-old woman was admitted with a four month history of 
lower back pain. Although a retroperitoneal tumor was found on sonography and 
CASTLEMAN's disease was included in the differential diagnosis, further imaging pro-
cedures such as computed tomography and angiography could not confirm the pre-
operative diagnosis of CASTLEMAN's disease. After the surgical removal of the tumor, 
the patient has been doing well with no evidence of recurrent disease.
       INTRODUCTION 
 CASTLEMAN'S disease is a rare benign lymphoid 
tumor of unknown etiology. Since CASTLEMAN, 
et all) first described a group of patients with 
a large thymoma-like mass in the anterior 
mediastinum, hundreds of cases have been 
reported in the literature. The mediastinum is 
the most common location, accounting for two-
thirds of the cases. The superficial form in-
volves the cervical, axillar, or inguinal lymph 
nodes and accounts for about 20% of the 
reported cases. The abdominal location is 
uncommon and this group consists of intra-
peritoneal and retroperitoneal tumors. Most 
of the retroperitoneal tumors are located in 
the pelvis, and the retroperitoneal tumors 
involving the pararenal area are rare2) . In this 
paper a case of retroperitoneal CASTLEMAN's 
tumor of hyalin-vascular type is reported. 
       CASE REPORT 
 A 58-year-old Japanese woman developed
lower back pain of four month duration. She 
was diagnosed as having a retroperitoneal 
tumor on a sonographic examination of the 
abdomen. She was admitted to the Department 
of Radiology, Nagasaki University Hospital in 
September 1987 for further evaluations of the 
tumor. Although CASTLEMAN'S disease was 
included at the top in the differential diagnosis, 
a definite preoperative diagnosis was not 
established. She was transferred to our care 
for extirpation of the tumor. Her past history 
included bronchial asthma requiring medication 
for years and an operation for uterine myoma 
at the age of 55. Her family history was not 
contributory. 
 A physical examination on admission revealed 
an obese and fit middle-aged woman with a 
previous operation scar along the lower midline 
of the abdomen. No tumor was palpated. 
Laboratory data showed no hematologic 
abnormalities, including a hemoglobin level of 
13.6g%, negative C-reactive protein, normal 
erythrocyte sedimentation rate of 13mm/hour, 
lactate dehydrogenase of 2 2 8 IU /L, total 
protein of 6.6g% with r-globulin of 17.3%.
Alpha-fetoprotein, carcinoembryonic antigen, 
and carbohydrate antigen 19-9 were all within 
normal limits. Serum levels of adrenaline, 
noradrenaline, dopamine were normal. There 
were no immunologic abnormalities. The OK-
T4 was 28.6% (normal : 30-45%) and OK-T8 
29.0% (normal : 25-35%). . 
 Abdominal sonography showed a hypoechoic 
sonolucent mass in the left paraortic region, 
measuring 3 cm by the greatest dimension 
(Fig. 1). Computed tomography (CT) revealed 
a well-demarcated homogenous mass of soft 
tissue density (Fig. 2), which was promptly 
and remarkably enhanced by contrast media. 
The abdominal aortic angiograms demonstrated 
the hypervascular tumor located between the 
left kidney and aorta. The left renal arterio-
grams provided no further information. The 
second lumber arteriograms showed a hypervas-
cular mass (Fig. 3) with no findings of malig-
nancy. Methyl iodo-benzyl guanidine (MIBG ) 
scintigrams revealed no uptake by the tumor 
on the corresponding area.
Fig. 3. Second lumber arteriography showing 
       a hypervascular mass with no malig-
      nant findings
Fig. 1. Abdominal sonography showing a hypo 
       echoic sonolucent mass in the left para-
       aortic region, measuring 3 cm by the 
       greatest dimension (arrows)
Fig. 2. Computed tomography (CT) revealing a 
       well-demarcated homogenous mass of
       soft tissue density (arrow)
 The operation was performed on October 6, 
1987. At laparotomy an elastic soft tumor 
surrounded by fat tissue was palpable between 
the aorta and left kidney. The left renal vessels 
were streched upwards over the superior surface 
of the tumor. The tumor appeared to be mainly 
perfused by branches of the lumber artery and 
drained via two branches into the left renal 
vein. The tumor was well-delineated and there 
were no findings of tumor invasion to the 
adjacent organs and structure. The tumor was 
extirpated together with the surrounding fat 
and two lymph nodes of the adjacent paraortic 
area. A frozen section during operation estab-
lished the diagnosis of CASTLEMAN's disease 
with no evidence for malignancy. 
 The resected tumor weighed 37 grams. Its 
cut surface showed a well-defined capsule and 
a homogeneous, greyish-white, fleshy texture 
with some scatterred small bleeding spots. 
Pathologic features on a permanent section 
confirmed a hyaline-vascular type of benign 
giant lymph node hyperplasia or CASTLEMAN'S 
disease. The lymph nodes obtained from the 
paraaortic area showed normal findings. 
 Her postoperative convalescence was unevent-
ful. At follow-up 1.5 years later the patient is 
well with no symptoms or signs of recurrent
Fig. 4. The cut surface of the resected tumor 
       showing a well-defined capsule and a 
       homogeneous, greyish-white and fleshy 
       texture with some scatterred small bleed-
       ing spots
disease on abdominal computed tomograohy 
(CT) and sonography as well as clinically.
Fig. 5. Pathological findings of the tumor show-
       ing a hyaline-vascular type of benign 
      giant lymph node hyperplasia or Castle-
       man's disease. A : hematoxylin-eosin
       stain X 10, B : hematoxylin eosin stain 
      X 50
        DISCUSSION 
 The etiology of CASTLEMAN'S disease still 
remains controversial. Some authors consider 
it an inflammatory process in origin and others 
suggest a hamartomatous origin 3) Some reports 
show markedly increased anti-Ebstein Barr 
(EB) virus antibody 4, 5) suggesting that EB 
virus be related to the etiology Of CASTLEMAN'S 
disease. 
 The lesions are discovered most often either 
on routine roentgenograms of the chest or
because of pressure symptoms. The lesions. 
sometimes manifest as palpable mass if outside 
the thorax. On sonography and CT scan the 
tumor manifests multinodular pattern. Angio-
grams show enlarged feeding vessels, dense 
homogeneous tumor stain, irregular hypervascu= 
larity, corresponding well to the prominent 
vasculature seen on histologic features6'.'l) . 
 KELLER and associates8) undertook a clinico-
pathological analysis of 81 cases of CASTLEMAN'S 
disease and identified two histopathologic 
subtypes :the hyaline-vascular type and 
plasma cell type. These subtypes of the disease 
reflect quite different clinical manifestations. 
The hyaline-vascular lesions are most numerous 
accounting for 91% of cases, and are characte-
rized by small hyalinized vascular follicles and 
interfollicular capillary proliferation. The 
plasma cell type, representing the remainder, 
are characterized by large follicles with inter-
vening sheets of plasma cells8). FLENDRIG9) ob-
served an intermediate group with the charac-
terized by large follicles with intervening 
sheets of plasma cells 8). FLENDRIG9) observed an 
intermediate group with the characteristics of 
the two types, which he called the transitional 
form. Approximately 70% of cases of hyaline 
type are present as a solitary mass, whereas 
multiple are predominant in plasma cell type 
(about 60%) 10). The plasma cell type is often 
associated with systemic manifestations. A 
number of unusual clinical entities have been 
associated with the plasma cell type of classi-
cal CASTLEMAN'S disease, including fever, anemia, 
hyperglobulinemia, amyloidosis, nephrotic 
syndrome, and thrombocytopenia. All of those 
have at least partially responded to surgical 
removal of the affected lymphoid mass. 
Extirpation of the tumor is, therefore, the 
treatment of choice. Local recurrence after 
operation does not occur. When symptoms 
persist, a diagnosis of partial removal of the 
lesion or of a multicentric type of the disease 
is indicated. If complete removal is not possible, 
even partial excision may be useful since 
regrowth of the tumor is not expected. Only a 
very small number of cases, however, evolve 
into malignant lymphoma 11 ? Radiotherapy has 
produced little or no shrinkage of CASTLEMAN'S 
      8) tumors.
  The recent literature, however, has described 
a highly lethal " multicentric " variant of 
classical CASTLEMAN'S disease with similar 
hyperplastic angio-follicular morphologic 
features and a positive human immunodeficien-
cy virus (HIV) , suggesting that HIV may be a 
potential etiopathogenetic agent on patients 
with generalized multicentric CASTLEMAN's 
diseasei2) 
 With the advance in several non-invasive 
modalities for diagnosis, it is anticipated that 
incidental detection of asymptomatic cases of 
CASTLEMAN's disease will be increaced. 
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